drugset
Drugs / Isoniazid Aminosalicylate
last change Dec 2016 re-read 2 minutes ago

Isoniazid Aminosalicylate

Developed for
pulmonary tuberculosis
Investigated by
Centers for Disease Control and Prevention · Jiangsu Province Centers for Disease Control and Prevention · Shanghai Center for Disease Control and Prevention · Shanghai Pulmonary Hospital, Shanghai, China · Zhejiang University

Trials 1 · a red edge is where a trial was stopped

today NCT02331823 · Ph 4
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02331823 Jun 2013 → Dec 2015 pulmonary tuberculosis Shanghai Pulmonary Hospital, Shanghai, China Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Isoniazid Aminosalicylate ClinicalTrials.gov intervention name — accepted as the source's own label NCT02331823 ↗
Route Oral “0.3g tid po for 5 mon” NCT02331823 ↗